CA Stock MarketDetailed Quotes
IME Imagin Medical Inc
- 0.015
- 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
162.45KMarket Cap-187P/E (TTM)
0.000High0.000Low0Volume0.000Open0.015Pre Close0.00Turnover0.07052wk High0.00%Turnover Ratio10.83MShares0.01052wk Low-0.08EPS TTM149.98KFloat Cap2655.000Historical HighLossP/E (Static)10.00MShs Float0.010Historical Low-0.25EPS LYR0.00%Amplitude--Dividend TTM-0.01P/B1Lot Size--Div YieldTTM
Imagin Medical Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -54.56%362.42K | -14.19%669.21K | -8.38%3.55M | -18.25%1.1M | -10.37%872.96K | -11.12%797.64K | 18.41%779.89K | -11.52%3.87M | 95.34%1.34M | 67.69%973.95K |
| Selling and administrative expenses | -30.64%315.53K | -4.77%323.9K | -31.04%1.46M | -72.09%178.78K | 0.79%481.2K | -17.22%454.95K | -23.12%340.14K | -4.93%2.11M | 18.39%640.56K | 11.77%477.44K |
| -General and administrative expense | -30.64%315.53K | -4.77%323.9K | -31.04%1.46M | -72.09%178.78K | 0.79%481.2K | -17.22%454.95K | -23.12%340.14K | -4.93%2.11M | 18.39%640.56K | 11.77%477.44K |
| Research and development costs | -99.83%553 | -30.81%298.99K | 18.01%2.05M | 28.69%895.57K | -21.48%384.11K | -1.58%335.04K | 106.85%432.1K | -18.44%1.73M | 427.07%695.9K | 230.86%489.17K |
| Depreciation amortization depletion | 505.62%46.33K | 505.62%46.33K | 60.38%47.13K | 229.14%24.18K | 4.12%7.65K | 4.14%7.65K | 4.12%7.65K | -8.67%29.39K | -50.54%7.35K | 27.22%7.35K |
| -Depreciation and amortization | 505.62%46.33K | 505.62%46.33K | 60.38%47.13K | 229.14%24.18K | 4.12%7.65K | 4.14%7.65K | 4.12%7.65K | -8.67%29.39K | -50.54%7.35K | 27.22%7.35K |
| Operating profit | 54.56%-362.42K | 14.19%-669.21K | 8.38%-3.55M | 18.25%-1.1M | 10.37%-872.96K | 11.12%-797.64K | -18.41%-779.89K | 11.52%-3.87M | -95.34%-1.34M | -67.69%-973.95K |
| Net non-operating interest income (expenses) | -39.28%-510.59K | -34.93%-2.28K | -13.06%-7.83K | -28.63%-2.19K | -50.41%-2.21K | -17,790.73%-366.58K | 0.88%-1.69K | -225.34%-6.93K | -756.76%-1.7K | -313.33%-1.47K |
| Non-operating interest income | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -17.18%1.44K | 34.93%2.28K | 13.06%7.83K | 28.63%2.19K | 50.41%2.21K | -15.08%1.74K | -0.88%1.69K | -12.48%6.93K | 6.98%1.7K | -24.67%1.47K |
| Total other finance cost | 39.55%509.14K | ---- | ---- | ---- | ---- | --364.84K | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -101.69%-270 | 227.10%687.48K | 114.02%1.06M | 47.68%-3.57M | 921.30%5.52M | 101.13%15.94K | -651.39%-540.91K | -178,131.97%-7.59M | -488,998.57%-6.82M | 20,168.08%540.63K |
| Gain on sale of security | -101.69%-270 | 127.19%1.4K | 161.95%23.3K | -86.01%2.95K | 144.67%9.56K | 168.97%15.94K | 63.65%-5.15K | -783.03%-37.62K | 1,610.40%21.06K | -694.54%-21.41K |
| Special income (charges) | ---- | 228.06%686.08K | 113.78%1.04M | 47.80%-3.57M | 880.71%5.51M | ---- | -577.29%-535.76K | ---7.56M | ---6.84M | --562.04K |
| -Less:Other special charges | ---- | -228.06%-686.08K | -113.78%-1.04M | -47.80%3.57M | -880.71%-5.51M | ---- | 577.29%535.76K | --7.56M | --6.84M | ---562.04K |
| Income before tax | 23.95%-873.27K | 101.21%15.99K | 78.28%-2.49M | 42.82%-4.67M | 1,168.64%4.65M | 50.35%-1.15M | -135.21%-1.32M | -162.14%-11.47M | -1,084.74%-8.16M | 25.40%-434.79K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 23.95%-873.27K | 101.21%15.99K | 78.28%-2.49M | 42.82%-4.67M | 1,168.64%4.65M | 50.35%-1.15M | -135.21%-1.32M | -162.14%-11.47M | -1,084.74%-8.16M | 25.40%-434.79K |
| Net income continuous operations | 23.95%-873.27K | 101.21%15.99K | 78.28%-2.49M | 42.82%-4.67M | 1,168.64%4.65M | 50.35%-1.15M | -135.21%-1.32M | -162.14%-11.47M | -1,084.74%-8.16M | 25.40%-434.79K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 23.95%-873.27K | 101.21%15.99K | 78.28%-2.49M | 42.82%-4.67M | 1,168.64%4.65M | 50.35%-1.15M | -135.21%-1.32M | -162.14%-11.47M | -1,084.74%-8.16M | 25.40%-434.79K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 23.95%-873.27K | 101.21%15.99K | 78.28%-2.49M | 42.82%-4.67M | 1,168.64%4.65M | 50.35%-1.15M | -135.21%-1.32M | -162.14%-11.47M | -1,084.74%-8.16M | 25.40%-434.79K |
| Diluted earnings per share | 33.33%-0.08 | 101.43%0.002 | 80.31%-0.25 | 47.78%-0.47 | 1,040.00%0.47 | 53.85%-0.12 | -133.33%-0.14 | -139.62%-1.27 | -1,185.71%-0.9 | 28.57%-0.05 |
| Basic earnings per share | 33.33%-0.08 | 101.43%0.002 | 80.31%-0.25 | 47.78%-0.47 | 1,040.00%0.47 | 53.85%-0.12 | -133.33%-0.14 | -139.62%-1.27 | -1,185.71%-0.9 | 28.57%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data